Characterization of D-maltose as a T2-exchange contrast agent for dynamic contrast-enhanced MRI

Joshua M. Goldenberg, Mark "Marty" Pagel, Julio Cárdenas-Rodríguez

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose: We sought to investigate the potential of D-maltose, D-sorbitol, and D-mannitol as T2 exchange magnetic resonance imaging (MRI) contrast agents. We also sought to compare the in vivo pharmacokinetics of D-maltose with D-glucose with dynamic contrast enhancement (DCE) MRI. Methods: T1 and T2 relaxation time constants of the saccharides were measured using eight pH values and nine concentrations. The effect of echo spacing in a multiecho acquisition sequence used for the T2 measurement was evaluated for all samples. Finally, performances of D-maltose and D-glucose during T2-weighted DCE-MRI were compared in vivo. Results: Estimated T2 relaxivities (r2) of D-glucose and D-maltose were highly and nonlinearly dependent on pH and echo spacing, reaching their maximum at pH=7.0 (∼0.08mM-1 s-1). The r2 values of D-sorbitol and D-mannitol were estimated to be ∼0.02mM-1 s-1 and were invariant to pH and echo spacing for pH ≤7.0. The change in T2 in tumor and muscle tissues remained constant after administration of D-maltose, whereas the change in T2 decreased in tumor and muscle after administration of D-glucose. Therefore, D-maltose has a longer time window for T2-weighted DCE-MRI in tumors. Conclusion: We have demonstrated that D-maltose can be used as a T2 exchange MRI contrast agent. The larger, sustained T2-weighted contrast from D-maltose relative to D-glucose has practical advantages for tumor diagnoses during T2-weighted DCE-MRI.

Original languageEnglish (US)
JournalMagnetic Resonance in Medicine
DOIs
StateAccepted/In press - Jan 1 2018
Externally publishedYes

Fingerprint

Maltose
Contrast Media
Magnetic Resonance Imaging
Glucose
Sorbitol
Mannitol
Neoplasms
Muscles
Pharmacokinetics

Keywords

  • D-maltose
  • DCE-MRI
  • T
  • Tumor imaging

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Characterization of D-maltose as a T2-exchange contrast agent for dynamic contrast-enhanced MRI. / Goldenberg, Joshua M.; Pagel, Mark "Marty"; Cárdenas-Rodríguez, Julio.

In: Magnetic Resonance in Medicine, 01.01.2018.

Research output: Contribution to journalArticle

@article{5057d08fd6d74a4e84b836bdb3d9e95b,
title = "Characterization of D-maltose as a T2-exchange contrast agent for dynamic contrast-enhanced MRI",
abstract = "Purpose: We sought to investigate the potential of D-maltose, D-sorbitol, and D-mannitol as T2 exchange magnetic resonance imaging (MRI) contrast agents. We also sought to compare the in vivo pharmacokinetics of D-maltose with D-glucose with dynamic contrast enhancement (DCE) MRI. Methods: T1 and T2 relaxation time constants of the saccharides were measured using eight pH values and nine concentrations. The effect of echo spacing in a multiecho acquisition sequence used for the T2 measurement was evaluated for all samples. Finally, performances of D-maltose and D-glucose during T2-weighted DCE-MRI were compared in vivo. Results: Estimated T2 relaxivities (r2) of D-glucose and D-maltose were highly and nonlinearly dependent on pH and echo spacing, reaching their maximum at pH=7.0 (∼0.08mM-1 s-1). The r2 values of D-sorbitol and D-mannitol were estimated to be ∼0.02mM-1 s-1 and were invariant to pH and echo spacing for pH ≤7.0. The change in T2 in tumor and muscle tissues remained constant after administration of D-maltose, whereas the change in T2 decreased in tumor and muscle after administration of D-glucose. Therefore, D-maltose has a longer time window for T2-weighted DCE-MRI in tumors. Conclusion: We have demonstrated that D-maltose can be used as a T2 exchange MRI contrast agent. The larger, sustained T2-weighted contrast from D-maltose relative to D-glucose has practical advantages for tumor diagnoses during T2-weighted DCE-MRI.",
keywords = "D-maltose, DCE-MRI, T, Tumor imaging",
author = "Goldenberg, {Joshua M.} and Pagel, {Mark {"}Marty{"}} and Julio C{\'a}rdenas-Rodr{\'i}guez",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/mrm.27082",
language = "English (US)",
journal = "Magnetic Resonance in Medicine",
issn = "0740-3194",
publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Characterization of D-maltose as a T2-exchange contrast agent for dynamic contrast-enhanced MRI

AU - Goldenberg, Joshua M.

AU - Pagel, Mark "Marty"

AU - Cárdenas-Rodríguez, Julio

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Purpose: We sought to investigate the potential of D-maltose, D-sorbitol, and D-mannitol as T2 exchange magnetic resonance imaging (MRI) contrast agents. We also sought to compare the in vivo pharmacokinetics of D-maltose with D-glucose with dynamic contrast enhancement (DCE) MRI. Methods: T1 and T2 relaxation time constants of the saccharides were measured using eight pH values and nine concentrations. The effect of echo spacing in a multiecho acquisition sequence used for the T2 measurement was evaluated for all samples. Finally, performances of D-maltose and D-glucose during T2-weighted DCE-MRI were compared in vivo. Results: Estimated T2 relaxivities (r2) of D-glucose and D-maltose were highly and nonlinearly dependent on pH and echo spacing, reaching their maximum at pH=7.0 (∼0.08mM-1 s-1). The r2 values of D-sorbitol and D-mannitol were estimated to be ∼0.02mM-1 s-1 and were invariant to pH and echo spacing for pH ≤7.0. The change in T2 in tumor and muscle tissues remained constant after administration of D-maltose, whereas the change in T2 decreased in tumor and muscle after administration of D-glucose. Therefore, D-maltose has a longer time window for T2-weighted DCE-MRI in tumors. Conclusion: We have demonstrated that D-maltose can be used as a T2 exchange MRI contrast agent. The larger, sustained T2-weighted contrast from D-maltose relative to D-glucose has practical advantages for tumor diagnoses during T2-weighted DCE-MRI.

AB - Purpose: We sought to investigate the potential of D-maltose, D-sorbitol, and D-mannitol as T2 exchange magnetic resonance imaging (MRI) contrast agents. We also sought to compare the in vivo pharmacokinetics of D-maltose with D-glucose with dynamic contrast enhancement (DCE) MRI. Methods: T1 and T2 relaxation time constants of the saccharides were measured using eight pH values and nine concentrations. The effect of echo spacing in a multiecho acquisition sequence used for the T2 measurement was evaluated for all samples. Finally, performances of D-maltose and D-glucose during T2-weighted DCE-MRI were compared in vivo. Results: Estimated T2 relaxivities (r2) of D-glucose and D-maltose were highly and nonlinearly dependent on pH and echo spacing, reaching their maximum at pH=7.0 (∼0.08mM-1 s-1). The r2 values of D-sorbitol and D-mannitol were estimated to be ∼0.02mM-1 s-1 and were invariant to pH and echo spacing for pH ≤7.0. The change in T2 in tumor and muscle tissues remained constant after administration of D-maltose, whereas the change in T2 decreased in tumor and muscle after administration of D-glucose. Therefore, D-maltose has a longer time window for T2-weighted DCE-MRI in tumors. Conclusion: We have demonstrated that D-maltose can be used as a T2 exchange MRI contrast agent. The larger, sustained T2-weighted contrast from D-maltose relative to D-glucose has practical advantages for tumor diagnoses during T2-weighted DCE-MRI.

KW - D-maltose

KW - DCE-MRI

KW - T

KW - Tumor imaging

UR - http://www.scopus.com/inward/record.url?scp=85041034667&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041034667&partnerID=8YFLogxK

U2 - 10.1002/mrm.27082

DO - 10.1002/mrm.27082

M3 - Article

C2 - 29369407

AN - SCOPUS:85041034667

JO - Magnetic Resonance in Medicine

JF - Magnetic Resonance in Medicine

SN - 0740-3194

ER -